加州尔湾--(BUSINESS WIRE)--(美国商业资讯)--Masimo(NASDAQ: MASI)今天宣布，为应对当前冠状病毒大流行导致的全球范围血液短缺，该公司正向使用rainbow ® 就绪器械的医院免费提供rainbow ® 许可证。Masimo rainbow ® 平台允许无创连续地监测12项参数，包括血红蛋白(SpHb ®)、氧 ...

瑞士纳沙泰尔--(BUSINESS WIRE)--(美国商业资讯)--Masimo(NASDAQ: MASI)今天宣布，单例患者使用的粘贴式rainbow ® SuperSensor™获得CE认证并在欧洲上市，该产品兼容Masimo和内置Masimo rainbow ® 技术的第三方监护仪。全面、便捷的多功能SuperSensor属业界首创，采用12枚LED无创连续 ...

IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the release of MX-7™, its latest and most advanced rainbow SET® board. Designed for integration into the more than 200 ...

IRVINE, Calif., Oct. 2, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced the conversion of Albany Medical Center (AMC), one of the biggest hospitals in the Capital (N.Y.) Region, to Masimo ...

Masimo has made a name for itself as a prolific purveyor of noninvasive patient monitoring technologies, from the SET pulse oximeter to the recently CE-marked Rainbow SuperSensor, which continuously ...

As part of the company’s focus on the development of advanced monitoring solutions, Royal Philips (NYSE: PHG; AEX: PHIA) today announced the launch of its IntelliVue patient monitoring platform with ...

A newly described small molecule inhibitor called AOH-1996 targets a cancer-associated isoform of PCNA (caPCNA), leading to a very broad therapeutic window.